BRN2 expression increases anoikis resistance in melanoma.

Pierce, Carly J; Simmons, Jacinta L; Broit, Natasa; Karunarathne, Deshapriya; Ng, Mei Fong; Boyle, Glen M

Pierce, Carly J; Simmons, Jacinta L; Broit, Natasa; Karunarathne, Deshapriya; Ng, Mei Fong; Boyle, Glen M.

Afiliação

Pierce CJ; Cancer Drug Mechanisms Group, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Simmons JL; Cancer Drug Mechanisms Group, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Broit N; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia.
Karunarathne D; School of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
Ng MF; Cancer Drug Mechanisms Group, Cell and Molecular Biology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
Boyle GM; Molecular Immunology Group, Immunology Department, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Oncogenesis ; 9(7): 64, 2020 Jul 06.

Article em En | MEDLINE | ID: mdl-32632141

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncogenesis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google